Linda Radford-Goad, CFNP
NPI 1013978022 · Family Nurse Practitioner · Galax, VA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1013978022
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- CFNP
- Sex
- Female
- Sole proprietor
- No
- License
- 0024103947 (VA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
230 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880 | 79 | $16 |
| Automated Urinalysis Test81003 | 63 | $2 |
| Respiratory Infectious Agent Detection By Rna for Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, and Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected0241U | 40 | $140 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Tracing93005 | 25 | $6 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 | 23 | $16 |
Typical Medicare-allowed amounts for these services range $2–$140 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 44 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 115 | 91 |
| Azithromycin | 107 | 96 |
| Methylprednisolone | 105 | 102 |
| Cephalexin | 67 | 62 |
| Amoxicillin | 58 | 54 |
| Mupirocin | 52 | 49 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 50 | 44 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$170 across 10 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-29
- Last updated
- 2023-01-10
- Certified
- 2023-01-10
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.